Patents by Inventor Ingrid Winkler

Ingrid Winkler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Spatial localization using augmented reality
    Patent number: 11182969
    Abstract: Methods and system for locating an event on an aircraft using augmented-reality content, an array of ultrasonic devices configured in mesh topology, and deep learning.
    Type: Grant
    Filed: October 29, 2019
    Date of Patent: November 23, 2021
    Assignees: EMBRAER S.A., SERVICO NACIONAL DE APRENDIZAGEM INDUSTRIAL, DEPARTMENTO REGINAL DE BAHIA—SENAI/DR/BA
    Inventors: Paulo Anchieta Da Silva, Gabriel de Oliveira Cruz Do Prado, Fabio Mitsuhiko Simomura, Andre Koji Fujimoto Tamba, Glauco Humberto Gomes, Kelson Luis de Oliveira Pereira, Flavio Soares Ribeiro Junior, Fabio Britto de Carvalho Almeida, Ingrid Winkler, Valéria Loureiro Da Silva
  • SPATIAL LOCALIZATION USING AUGMENTED REALITY
    Publication number: 20210125410
    Abstract: Methods and system for locating an event on an aircraft using augmented-reality content, an array of ultrasonic devices configured in mesh topology, and deep learning.
    Type: Application
    Filed: October 29, 2019
    Publication date: April 29, 2021
    Inventors: Paulo Anchieta DA SILVA, Gabriel de Oliveira Cruz DO PRADO, Fabio Mitsuhiko SIMOMURA, Andre Koji Fujimoto TAMBA, Glauco Humberto GOMES, Kelson Luis de Oliveira PEREIRA, Flavio Soares RIBEIRO JUNIOR, Fabio Britto de Carvalho ALMEIDA, Ingrid WINKLER, Valéria Loureiro DA SILVA
  • Treatment of immunocompromised conditions
    Patent number: 9486497
    Abstract: This invention discloses the use of an E-selectin antagonist in methods and compositions for treating or preventing immunocompromised conditions resulting from medical treatment. The present invention is particular useful for prophylaxis and/or treatment of hematopoietic disorders including neutropenia, agranulocytosis, anemia and thrombocytopenia in individuals receiving or proposed to receive treatments that target rapidly dividing cells or that disrupt the cell cycle or cell division.
    Type: Grant
    Filed: November 7, 2008
    Date of Patent: November 8, 2016
    Assignee: THE UNIVERSITY OF QUEENSLAND
    Inventors: Jean-Pierre Levesque, Ingrid Winkler
  • COMPOSITIONS COMPRISING E-SELECTIN ANTAGONISTS AND USES THEREFOR
    Publication number: 20160193294
    Abstract: This invention discloses the use of an E-selectin antagonist and a mobilizer of hematopoietic stem cells or progenitor cells in methods and compositions for treating or preventing immunocompromised conditions resulting from medical treatment. The present invention is particular relevant for prophylaxis and/or treatment of hematopoeitic disorders including neutropenia, agranulocytosis, anemia and thrombocytopenia in individuals receiving or proposed to receive treatments that target rapidly dividing cells or that disrupt the cell cycle or cell division.
    Type: Application
    Filed: December 30, 2015
    Publication date: July 7, 2016
    Applicant: THE UNIVERSITY OF QUEENSLAND
    Inventors: Jean-Pierre Levesque, Ingrid Winkler
  • Compositions comprising E-selectin antagonists and uses therefor
    Patent number: 9254322
    Abstract: This invention discloses the use of an E-selectin antagonist and a mobilizer of hematopoietic stem cells or progenitor cells in methods and compositions for treating or preventing immunocompromised conditions resulting from medical treatment. The present invention is particular relevant for prophylaxis and/or treatment of hematopoeitic disorders including neutropenia, agranulocytosis, anemia and thrombocytopenia in individuals receiving or proposed to receive treatments that target rapidly dividing cells or that disrupt the cell cycle or cell division.
    Type: Grant
    Filed: December 9, 2008
    Date of Patent: February 9, 2016
    Assignee: The University of Queensland
    Inventors: Jean-Pierre Levesque, Ingrid Winkler
  • TREATMENT AND PROPHYLAXIS
    Publication number: 20110020270
    Abstract: This invention discloses the use of an E-selectin antagonist and a mobilizer of hematopoietic stem cells or progenitor cells in methods and compositions for treating or preventing immunocompromised conditions resulting from medical treatment. The present invention is particular relevant for prophylaxis and/or treatment of hematopoeitic disorders including neutropenia, agranulocytosis, anemia and thrombocytopenia in individuals receiving or proposed to receive treatments that target rapidly dividing cells or that disrupt the cell cycle or cell division.
    Type: Application
    Filed: December 9, 2008
    Publication date: January 27, 2011
    Inventors: Jean-Pierre Levesque, Ingrid Winkler
  • TREATMENT AND PROPHYLAXIS
    Publication number: 20110002881
    Abstract: This invention discloses the use of an E-selectin antagonist in methods and compositions for treating or preventing immunocompromised conditions resulting from medical treatment. The present invention is particular useful for prophylaxis and/or treatment of hematopoietic disorders including neutropenia, agranulocytosis, anemia and thrombocytopenia in individuals receiving or proposed to receive treatments that target rapidly dividing cells or that disrupt the cell cycle or cell division.
    Type: Application
    Filed: November 7, 2008
    Publication date: January 6, 2011
    Applicant: Mater Medical Research Institute
    Inventors: Jean-Pierre Levesque, Ingrid Winkler